Strategies for Selecting the Proper Investigational Sites for Pivotal Studies

In this episode of NAMSA’s MedTech Matters video series, Dr. Ken Ouriel (Chief Medical Officer) discusses the art of site selection for clinical trials and what to watch for—supportiveness, investigational expertise and well-placed Key Opinion Leaders (KOLs). Plus, see how partnering with a CRO like NAMSA can aid smaller and medium-sized companies in navigating the journey to market success.

To learn about how NAMSA can accelerate your clinical research goals, please visit: https://namsa.com/services/clinical-research/ 

Schedule a complimentary consultation with our global experts at: https://namsa.com/namsa-expertise/subject-matter-experts/.